THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS

Introduction. The purpose of this study was to evaluate the feasibility of using 99mTc-TG SPECT in the detection and staging of malignant lymphoma.Materials and methods. Fifteen patients with newly diagnosed malignant lymphoma  underwent 99mTc-TG SPECT. Six patients had Hodgkin’s lymphoma and 9 pati...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Chernov, E. A. Dudnikova, R. V. Zelchan, T. L. Kravchuk, A. V. Danilova, A. A. Medvedeva, I. G. Sinilkin, O. D. Bragina, V. E. Goldberg, A. V. Goldberg, I. G. Frolova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2018-09-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/820
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850030692161814528
author V. I. Chernov
E. A. Dudnikova
R. V. Zelchan
T. L. Kravchuk
A. V. Danilova
A. A. Medvedeva
I. G. Sinilkin
O. D. Bragina
V. E. Goldberg
A. V. Goldberg
I. G. Frolova
author_facet V. I. Chernov
E. A. Dudnikova
R. V. Zelchan
T. L. Kravchuk
A. V. Danilova
A. A. Medvedeva
I. G. Sinilkin
O. D. Bragina
V. E. Goldberg
A. V. Goldberg
I. G. Frolova
author_sort V. I. Chernov
collection DOAJ
description Introduction. The purpose of this study was to evaluate the feasibility of using 99mTc-TG SPECT in the detection and staging of malignant lymphoma.Materials and methods. Fifteen patients with newly diagnosed malignant lymphoma  underwent 99mTc-TG SPECT. Six patients had Hodgkin’s lymphoma and 9 patients had aggressive forms of non-Hodgkin’s lymphoma (NHL): diffuse large B-cell lymphoma (7  cases), B-cell follicular lymphoma (1 case), and lymphoma from B cells in the marginal zone  (1 case). Stage IIA was diagnosed in 5 patients, stage IIB in 1, stage IIIA in 1, stage IVA in 4 and stage IVB in 4 patients.Results. Pathological 99mTc-TG uptake in lymph nodes was observed in 14 (93 %) of the  15 patients. In one patient, the enlarged submandibular lymph node (16 mm in size)  detected by CT was not visualized by 99mTc-TG SPECT. This false-negative result was likely  to be associated with increased accumulation of 99mTc-TG in the oropharyngeal region.  There were difficulties in the visualization of paratracheal, para-aortic and paracardial lymph  nodes. These difficulties were associated with a high blood background activity, which  persisted even 4 hours after intravenous injection of 99mTc-TG. Software-based SPECT and  CT image fusion allowed visualization of these lymph nodes. The pathological 99mTc-TG  accumulation in axillary, supraclavicular, infraclavicular and cervical lymph nodes was  observed most often. Extranodal involvement was seen in 9 patients. 99mTc-TG SPECT identified extranodal hypermetabolic lesions in 7 (78 %) of these patients. In one  patient, hypermetabolic lesion in the lung detected by 99mTc-TG SPECT was not detected on CT image. CT identified bone marrow involvement in the pelvic and scapula in 1 patient. The  use of 99mTc-TG SPECT allowed the visualization of hypermetabolic bone tissue lesions  in this patient (Figure 4). In addition, in a patient with intact bone tissue on CT, 99mTc-TG SPECT detected hypermetabolic lesions in the iliac bone.Conclusion. 99mTc-1-Thio-D-glucose demonstrated increased uptake in nodal and  extranodal sites of lymphoma. The results indicate that SPECT with 99mTc-1-Thio-D-glucose is a feasible and useful tool in the detection and staging malignant lymphoma.
format Article
id doaj-art-0647224201cc481da13100a8ee5b635f
institution DOAJ
issn 1814-4861
2312-3168
language Russian
publishDate 2018-09-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-0647224201cc481da13100a8ee5b635f2025-08-20T02:59:08ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682018-09-01174818710.21294/1814-4861-2018-17-4-81-87566THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMASV. I. Chernov0E. A. Dudnikova1R. V. Zelchan2T. L. Kravchuk3A. V. Danilova4A. A. Medvedeva5I. G. Sinilkin6O. D. Bragina7V. E. Goldberg8A. V. Goldberg9I. G. Frolova10Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences National Research Tomsk Polytechnic UniversityCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesIntroduction. The purpose of this study was to evaluate the feasibility of using 99mTc-TG SPECT in the detection and staging of malignant lymphoma.Materials and methods. Fifteen patients with newly diagnosed malignant lymphoma  underwent 99mTc-TG SPECT. Six patients had Hodgkin’s lymphoma and 9 patients had aggressive forms of non-Hodgkin’s lymphoma (NHL): diffuse large B-cell lymphoma (7  cases), B-cell follicular lymphoma (1 case), and lymphoma from B cells in the marginal zone  (1 case). Stage IIA was diagnosed in 5 patients, stage IIB in 1, stage IIIA in 1, stage IVA in 4 and stage IVB in 4 patients.Results. Pathological 99mTc-TG uptake in lymph nodes was observed in 14 (93 %) of the  15 patients. In one patient, the enlarged submandibular lymph node (16 mm in size)  detected by CT was not visualized by 99mTc-TG SPECT. This false-negative result was likely  to be associated with increased accumulation of 99mTc-TG in the oropharyngeal region.  There were difficulties in the visualization of paratracheal, para-aortic and paracardial lymph  nodes. These difficulties were associated with a high blood background activity, which  persisted even 4 hours after intravenous injection of 99mTc-TG. Software-based SPECT and  CT image fusion allowed visualization of these lymph nodes. The pathological 99mTc-TG  accumulation in axillary, supraclavicular, infraclavicular and cervical lymph nodes was  observed most often. Extranodal involvement was seen in 9 patients. 99mTc-TG SPECT identified extranodal hypermetabolic lesions in 7 (78 %) of these patients. In one  patient, hypermetabolic lesion in the lung detected by 99mTc-TG SPECT was not detected on CT image. CT identified bone marrow involvement in the pelvic and scapula in 1 patient. The  use of 99mTc-TG SPECT allowed the visualization of hypermetabolic bone tissue lesions  in this patient (Figure 4). In addition, in a patient with intact bone tissue on CT, 99mTc-TG SPECT detected hypermetabolic lesions in the iliac bone.Conclusion. 99mTc-1-Thio-D-glucose demonstrated increased uptake in nodal and  extranodal sites of lymphoma. The results indicate that SPECT with 99mTc-1-Thio-D-glucose is a feasible and useful tool in the detection and staging malignant lymphoma.https://www.siboncoj.ru/jour/article/view/820lymphomashodgkin’s lymphomanon-hodgkin’s lymphomassingle-photon emission computed tomography99mtc-1-thio-d-glucose
spellingShingle V. I. Chernov
E. A. Dudnikova
R. V. Zelchan
T. L. Kravchuk
A. V. Danilova
A. A. Medvedeva
I. G. Sinilkin
O. D. Bragina
V. E. Goldberg
A. V. Goldberg
I. G. Frolova
THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
Сибирский онкологический журнал
lymphomas
hodgkin’s lymphoma
non-hodgkin’s lymphomas
single-photon emission computed tomography
99mtc-1-thio-d-glucose
title THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
title_full THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
title_fullStr THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
title_full_unstemmed THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
title_short THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
title_sort first experience of using 99mtc 1 thio d glucose for single photon emission computed tomography imaging of lymphomas
topic lymphomas
hodgkin’s lymphoma
non-hodgkin’s lymphomas
single-photon emission computed tomography
99mtc-1-thio-d-glucose
url https://www.siboncoj.ru/jour/article/view/820
work_keys_str_mv AT vichernov thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT eadudnikova thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT rvzelchan thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT tlkravchuk thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT avdanilova thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT aamedvedeva thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT igsinilkin thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT odbragina thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT vegoldberg thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT avgoldberg thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT igfrolova thefirstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT vichernov firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT eadudnikova firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT rvzelchan firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT tlkravchuk firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT avdanilova firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT aamedvedeva firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT igsinilkin firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT odbragina firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT vegoldberg firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT avgoldberg firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas
AT igfrolova firstexperienceofusing99mtc1thiodglucoseforsinglephotonemissioncomputedtomographyimagingoflymphomas